Spots Global Cancer Trial Database for metastatic breast neoplasm
Every month we try and update this database with for metastatic breast neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer | NCT00430001 | Breast Cancer | docetaxel vinorelbine trastuzumab | 18 Years - 74 Years | Danish Breast Cancer Cooperative Group | |
| Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer | NCT00430001 | Breast Cancer | docetaxel vinorelbine trastuzumab | 18 Years - 74 Years | Danish Breast Cancer Cooperative Group | |
| Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer | NCT00430001 | Breast Cancer | docetaxel vinorelbine trastuzumab | 18 Years - 74 Years | Danish Breast Cancer Cooperative Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
